Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Medication Documentation and Availability Discrepancies

Reno, Nevada Survey Completed on 05-15-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that there were no discrepancies between a resident's available medications, the resident's medication orders, and the medication administration record (MAR). During a review of a resident's medications, a bottle of lorazepam was found in the medication storage room with a label indicating it was prescribed for the resident, with specific administration instructions. However, the facility's electronic health record did not include an order for lorazepam, and the medication was not listed on the resident's MAR. The RN confirmed that the medication had been delivered by the hospice agency's pharmacy, but it was not properly documented in the facility's records. Additionally, the resident had an order for C-PDR cream to be applied as needed for nausea or vomiting, which was part of the hospice comfort package. The RN stated that the facility did not have the C-PDR cream available for the resident. The Director of Nursing confirmed that all medications ordered for a resident should be available in the facility. Facility policy required that a current list of orders be maintained in the clinical record for each resident, and the pharmacy services contract required regular medication regimen reviews by a consultant pharmacist.

An unhandled error has occurred. Reload 🗙